(Reuters) – England’s National Health Services plans to offer Eli Lilly’s weight-loss drugs to nearly a quarter million people as part of a three-year plan, UK’s drugs cost regulator said on Thursday.
(Reporting by Kashish Tandon in Bengaluru; Editing by Leroy Leo)
